Switzerland: Market and legal data analysis of the cannabis sector

10th April 2024: Switzerland: The city of Lucerne has started to register participants in the pilot project for the sale of recreational cannabis. Participants will be able to obtain cannabis products such as flower, hashish, e-liquids and tinctures, which have been specially produced for the study, tested in laboratories and packaged in neutral packaging, from designated pharmacies for a maximum of 24 months. Sales of the products are expected to begin in summer 2024.
8th April 2024: Switzerland: This week, the recreational cannabis project starts in the city of Bern. Around 700 study participants will take part in the project and will be able to buy cannabis in selected pharmacies. The products available include flowers, resins, sprays and e-liquids. The study will examine the effects of a combined sales and counselling intervention on users’ behaviour and health, and the resulting scientific evidence will contribute to the debate on future cannabis policy in Switzerland.
26th March 2024: Switzerland: The canton of Basel-Stadt has published the first results of the pilot project for the sale of cannabis for non-medical purposes, which started in January 2023. A total of 378 people were involved in the project and 41 kg of cannabis was sold in pharmacies. In addition to the flower and hash products available, 67% of participants said they wanted other products such as edibles, THC oil and e-liquids. The head of the project said: "Overall, no incidents and no increase in cannabis use were found during the first year of the study". The study will last until July 2025 and a final report will be prepared for a future discussion on a national cannabis policy.
19th March 2024: Switzerland: The Federal Office of Public Health (FOPH) has given its approval to the canton of Zurich to sell recreational cannabis as a pilot project, media reports. Allegedly, it would be the largest study to date carried out in the country, with 5,000 participants over five years. Sales will be allowed in specialist shops and pharmacies in seven municipalities from May 2024. The aim of the study is to examine the economic and social effects of cannabis legalisation. Other similar pilot projects have already been launched in the cities of Zurich, Basel and Lausanne, as well as in the cantons of Basel-Stadt, Geneva and Basel-Landschaft.
18th March 2024: Switzerland: The University of Zurich has published the first results of the Züri Can project, one of the pilot projects for the sale of cannabis for non-medical purposes, which started on 22nd August 2023. The results show that 21 outlets were available (10 pharmacies, 10 cannabis clubs and 1 drug information centre), 1,928 people participated in the project, and 16,500 sales of flower and hashish were made.
12th December 2023: Switzerland: Following the approval by the Federal Office of Public Health (FOPH) in October 2023 to carry out pilot projects for the controlled distribution of recreational cannabis, the first of two cannabis dispensaries has opened in the municipality of Allschwil. It is said to be the first legal cannabis shop in Europe, and 3,950 people are participating in the project. The prices of cannabis flowers vary between CHF8 (€8) and CHF12 (€12), depending on THC content. Other pilot projects, such as those in Zurich and Basel-Stadt, have already been approved by the FOPH and products have been sold in pharmacies.
2nd November 2023: Switzerland: The Federal Council has issued a report, at the request of the National Council, to examine “how the various forms of the hemp plant (cannabis) could be made more economically usable and how a contemporary and comprehensive cannabis regulation could be enacted”. In summary, the Federal Council does not consider a comprehensive regulation of cannabis and hemp to be appropriate, since a specific law would encompass areas that are already regulated by other laws, such as cannabis for medical purposes. On the other hand, recreational cannabis should be regulated in a new special law, taking into account the experiences of the pilot tests currently being conducted.
25th October 2023: Switzerland: The German Sanity Group and the Swiss Institute for Addiction and Health Research (ISGF) have received final approval from the Federal Office of Public Health (FOPH) to carry out a pilot project for the controlled distribution of recreational cannabis in the canton of Basel-Landschaft, more specifically in the towns of Allschwil and Liestal. Allegedly, this is the first time that the FOPH has granted permission to a foreign company with commercial interests to operate the cannabis dispensaries for the pilot projects. Other pilot projects, such as those in Zurich, Lausanne and Geneva, have already been approved by the FOPH.
23rd August 2023: Switzerland: The city of Zurich has launched its first supply of cannabis products as part of its pilot project for the sale of recreational cannabis, which was approved by the Federal Office of Public Health (FOPH) in March 2023. Selling prices vary between CHF7.20 (€7.55) and CHF9.60 (€10) depending on the THC and CBD content. The product range includes three flower and two hashish varieties.
25th July 2023: Switzerland: The Federal Supreme Court has ruled that a small amount of cannabis for personal consumption, up to 10 g, cannot be seized for destruction. The court said that, since possession of up to 10 g is not punishable by law, there is no legal basis for confiscation.
10th May 2023: Switzerland: The Federal Office of Public Health has given its approval to the cities of Bern, Lucerne and Biel to sell recreational cannabis in pharmacies as a pilot project. The project, involving over 1,000 participants, is expected to start in Bern in the autumn and in Lucerne and Biel at the beginning of 2024.

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis

LATEST ALERTS

Cannabis and cannabinoids in Switzerland

News analysis

The uncertain fate of IHDCs in Europe: could a general ban be on the horizon?

Is the cannabis sector failing to ensure gender equality at its own expense?

Relaxation beats intoxication – IHDC sales aren’t just about getting high

Switzerland’s recreational cannabis pilot projects under criticism from within

Developing countries could get economic boost from industrial hemp, says UN

Alerts

Market reports

Switzerland: medical cannabis snapshot

Intoxicating hemp-derived cannabinoids: the European online market

Switzerland: CBD and cannabis snapshot

Online retailer report: the Swiss market

Top brands & pricing report: the Swiss market, Q4 2020 – overview

Regulatory reports

Switzerland: medical cannabis snapshot

A European country analysis of intoxicating hemp-derived cannabinoids

Switzerland: CBD and cannabis snapshot

Switzerland: CBD and cannabis regulation, May 2022

Medical and recreational cannabis – a global overview

Market data

Switzerland CBD insights dashboard, 2023

Switzerland: online retailer status, Q1 2023

CBD and IHDC online retailer database

Online retailer status: Switzerland

Switzerland CBD insights dashboard, Q1 2022

Regulatory databases

CannIntelligence policy tracker

Regulatory tracker: current global regulation of CBD, February

Regulatory tracker: current global regulation of recreational cannabis

Regulatory tracker: current global regulation of medical cannabis

Regulatory tracker: HHC in Europe, February

Sign up to our newsletter